GlucoGuard

搜索文档
American Diversified Holdings Corporation (ADHC) Provides Udpate on Arete Bioscience GlucoGuard Design Project
Newsfile· 2025-07-14 20:00
Arete will be conducting an usability study including approximately ten participants to establish the wearability and comfort of the device as directed by the FDA. It is anticipated that Arete will complete the project in the next 7 to 10 days. Arete BioScience's team of scientists and biomechanical engineers have completed a review of GlucoGuard's foundational documentation including intellectual property, design schematics, and FDA application documentation. The team has devised a development protocol tha ...